Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | TYR | P14679 | 2/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.50 |
| ▸ | FOS | P01100 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | JUN | P05412 | 1/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.50 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22808307 | 0.84 | TSHR (0.58) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL6232129 | 0.81 | TSHR (0.57) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL5072122 | 0.79 | BCHE (0.73) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL30491037 | 0.79 | BCHE (0.73) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL29761292 | 0.77 | TSHR (0.77) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL178482 | 0.77 | TSHR (0.62) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL17295977 | 0.77 | TSHR (0.62) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL8082807 | 0.77 | TSHR (0.77) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL20563424 | 0.76 | TSHR (0.65) | TSHRCYP3A4NFKB1BLMPMP22 | |
| SCHEMBL1595549 | 0.76 | TSHR (0.65) | TSHRCYP3A4NFKB1BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| US-20200246573-A1 | NITRIC OXIDE INHALATION THERAPY FOR INFANTS WITH BRONCHIOLITIS | STREETERVILLE CAPITAL, LLC | 2020-08-06 | — | — | US | claimed |
| US-9499587-B2 | Gamma-AApeptides with potent and broad-spectrum antimicrobial activity | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-11-22 | — | — | US | claimed |
| US-20150274782-A1 | GAMMA-AAPEPTIDES WITH POTENT AND BROAD-SPECTRUM ANTIMICROBIAL ACTIVITY | UNIVERSITY OF SOUTH FLORIDA (US) | 2015-10-01 | — | — | US | claimed |
| WO-2013112548-A1 | GAMMA-AAPEPTIDES WITH POTENT AND BROAD-SPECTRUM ANTIMICROBIAL ACTIVITY | UNIVERSITY OF SOUTH FLORIDA (US) | 2013-08-01 | — | — | WO | claimed |
| EP-4548975-A2 | NITRIC OXIDE INHALATION THERAPY FOR INFANTS WITH BRONCHIOLITIS | Beyond Air Ltd (IL) | 2025-05-07 | — | — | EP | disclosed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | disclosed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | disclosed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | disclosed |
| EP-3655009-B1 | NANOPARTICLE COMPOSITIONS | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2023-10-11 | — | — | EP | disclosed |
| US-11660270-B2 | Nanoparticle compositions | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2023-05-30 | — | — | US | disclosed |
| WO-2009090648-A2 | USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2009-07-23 | — | — | WO | disclosed |
| US-7504381-B2 | Antimicrobial agents | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2009-03-17 | — | — | US | disclosed |
| WO-2008132737-A1 | NOVEL ANTIMICROBIAL AGENTS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2008-11-06 | — | — | WO | disclosed |
| EP-1793837-A2 | FATTY ACID MODIFIED POLYLYSINES AS ANTIMICROBIAL AGENTS | Technion Research & Development Foundation Limited (IL) | 2007-06-13 | — | — | EP | disclosed |
| US-20070032428-A1 | Novel antimicrobial agents | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2007-02-08 | — | — | US | disclosed |
| US-20060074021-A1 | Novel antimicrobial agents | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2006-04-06 | — | — | US | disclosed |
| WO-2006035431-A2 | FATTY ACID MODIFIED POLYLYSINES AS ANTIMICROBIAL AGENTS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2006-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074021-A1 | Novel antimicrobial agents | NOTUM, DAO, SLC11A2 | TSHR 3555/4885CYP3A4 2925/4885NFKB1 1533/4885 |
| US-20070032428-A1 | Novel antimicrobial agents | NOTUM, DAO, SLC11A2 | TSHR 3555/4885CYP3A4 2925/4885NFKB1 1533/4885 |
| US-20150274782-A1 | GAMMA-AAPEPTIDES WITH POTENT AND BROAD-SPECTRUM ANTIMICROBIAL ACTIVITY | ANPEP, DNPEP, ENPEP | TSHR 3299/4885CYP3A4 2808/4885NFKB1 2821/4885 |
| US-11660270-B2 | Nanoparticle compositions | NAPEPLD, PHOSPHO1, LIPA | TSHR 4783/4885CYP3A4 2836/4885NFKB1 1140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.